Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13817438 | 1.00 | ADORA2A (1.00) | ADORA2AADORA2B | |
| SCHEMBL13817178 | 1.00 | ADORA2A (1.00) | ADORA2AADORA2B | |
| SCHEMBL13403867 | 1.00 | ADORA2A (1.00) | ADORA2AADORA2B | |
| SCHEMBL272621 | 1.00 | ADORA2A (1.00) | ADORA2AADORA2B | |
| SCHEMBL13403866 | 0.88 | ADORA2A (0.78) | ADORA2A | |
| SCHEMBL13437722 | 0.88 | ADORA2A (0.78) | ADORA2A | |
| SCHEMBL272005 | 0.88 | ADORA2A (0.78) | ADORA2A | |
| SCHEMBL272622 | 0.85 | ADORA2A (0.89) | ADORA2AADORA2B | |
| SCHEMBL2367743 | 0.85 | ADORA2A (0.89) | ADORA2AADORA2B | |
| SCHEMBL7804687 | 0.82 | ADORA2A (1.00) | ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2056834-B1 | METHODS AND COMPOSITIONS FOR INCREASING PATIENT TOLERABILITY DURING MYOCARDIAL IMAGING METHODS | GILEAD SCIENCES INC (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2366396-A1 | Myocardial perfusion imaging using adenosine receptor agonists | Gilead Palo Alto, Inc. (US) | 2011-09-21 | — | — | EP | disclosed |